PTPRC and neoplasm: Finally, we assessed the expression of different co-inhibitory receptors/ligands in tumor cells, which revealed that these CD45- cells predominantly expressed PD-L1 but not PD-L2, VISTA and Gal-9 (Supplementary Fig. S1H, I).